As of the end of 2025, the market in Canada generated a value of USD 14.57 billion.
Projections estimate the Canada Infusion Services Market size will climb to USD 32.53 billion by 2033, registering a CAGR of 10.6% during the forecast period.
Provincial drug funding programs continue expanding biologic reimbursement, particularly for inflammatory and oncology conditions, strengthening outpatient infusion throughput within public hospital systems.
The Canadian Institute for Health Information reports sustained cancer treatment activity growth, indicating stable infusion demand across major provinces.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]